-
GS-441524: Mechanism, PK, and Research Workflows
2026-08-24
GS-441524 is an adenine nucleoside analog studied for conversion to an active triphosphate antiviral metabolite. Recent LC–MS/MS work maps GS-441524 prodrug conversion across gastric, blood, liver, and animal pharmacokinetic models, while product-specific handling data define solvent, storage, and quality-control requirements.
-
Diphenyleneiodonium chloride for Reliable Assays
2026-08-23
Learn how Diphenyleneiodonium chloride (DPI, SKU B6326) can clarify redox-dependent viability results, cAMP signaling modulation, and oxidative stress experiments. This scenario-based guide covers formulation, controls, protocol optimization, interpretation, and practical product selection.
-
Moxifloxacin Workflows for Gyrase and Toxicity
2026-08-22
Build reproducible Moxifloxacin assays that connect bacterial DNA gyrase inhibition with retinal ganglion cell viability and metabolic-response studies. This guide combines fresh-solution handling, concentration design, mechanistic controls, and troubleshooting for antibiotic toxicity research.
-
TBXA2R–ERM Signaling in TNBC Metastasis
2026-08-21
The reference study identifies TBXA2R as an upstream GPCR activator of ezrin, radixin, and moesin, linking receptor signaling to cytoskeletal remodeling in triple-negative breast cancer. Its results connect G-protein, Rho GTPase, and SLK/LOK kinase signaling with tumor-cell motility, invasion, and metastatic colonization, while highlighting ERM function as a mechanistic dependency.
-
GS-441524: Mechanism, Evidence, and Research Use
2026-08-21
GS-441524 is a nucleoside analog that can be phosphorylated intracellularly to an active triphosphate metabolite targeting viral RNA synthesis. Current evidence supports GS-441524 antiviral research, prodrug-conversion studies, and pharmacokinetic assay development, but product purity and in vitro activity should not be interpreted as clinical efficacy.
-
Remdesivir and the Polymerase Frontier
2026-08-20
Remdesivir (GS-5734) offers translational researchers a practical bridge between nucleoside analogue pharmacology, RNA virus replication biology, and emerging polymerase structures. This article examines the evidence supporting its use in coronavirus and Ebola virus research, explains how Nipah virus polymerase architecture expands the strategic framework, and outlines disciplined workflows for interpreting potency without overextending the data.
-
SAF312 (Libvatrep): Ocular TRPV1 Pharmacology
2026-08-20
The reference study establishes an integrated preclinical profile for SAF312 (libvatrep), combining human ocular tissue expression, receptor pharmacology, ocular pharmacokinetics, toxicology, and corneal wound-healing analysis. Its findings support localized, selective TRPV1 antagonism as a potential strategy for ocular surface pain while defining the evidence and limitations that must be addressed before clinical translation.
-
Patient-Derived Gastric Cancer Assembloids Explained
2026-08-19
This 2025 study introduces patient-derived gastric cancer assembloids that combine matched tumor organoids with tumor-derived stromal subpopulations, including fibroblasts, mesenchymal stem cells, and endothelial cells. The model captures clinically relevant tumor–stroma effects on gene expression and drug response, providing a more physiologically informative platform for gastric cancer research and personalized treatment assessment.
-
Disulfiram Workflows for Proteasome and Cancer Research
2026-08-19
Disulfiram supports paired proteasome, apoptosis, and inflammasome experiments rather than a single-endpoint screening strategy. This guide translates its copper-sensitive activity and cancer-cell applications into practical workflows with controls, assay choices, and troubleshooting safeguards.
-
Y-27632: Practical ROCK Inhibitor Workflow Guide
2026-08-18
Y-27632 (SKU B1293) is a research-use ROCK inhibitor for controlled ROCK1/ROCK2 inhibition, cytoskeletal dynamics modulation, and cell stress fiber disruption. This guide focuses on dose and exposure planning, solvent handling, and assay QC; it should not be used to infer clinical efficacy, diagnostic performance, or universal behavior across cell types.
-
Cl-Amidine: PAD4 Assays Under Stress
2026-08-18
Cl-Amidine trifluoroacetate salt enables selective interrogation of PAD4 activity across biochemical, cancer, inflammatory, and septic shock models. This guide connects PAD4 assay design with ribotoxic-stress biology while separating direct evidence from testable hypotheses.
-
Molnupiravir and Bourbon Virus Disease in Mice
2026-08-17
The reference study provides a preclinical evaluation of molnupiravir against lethal Bourbon virus infection, combining antiviral, survival, hematologic, immune, and tissue-pathology endpoints in mice. Its findings support further investigation of an orally available nucleoside analogue while underscoring the need to validate efficacy across virus-specific models and treatment windows.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-17
Liu et al. identify a secretase-dependent Neuroligin 1 cleavage pathway in the ventral hippocampus that converts social interaction into a sustained intracellular signal. The resulting NLG1-CTD fragment engages PDZ-dependent cofilin signaling, promotes dendritic spine remodeling, and supports the maintenance of recently acquired social memories.
-
Metoprolol Tartrate in β1 Signaling Assays
2026-08-16
Metoprolol Tartrate gives researchers a selective way to separate cardiac β1-adrenergic signaling from broader β-blockade. Its water compatibility, defined purity, and utility in both cardiomyocyte assays and hematopoietic regeneration studies support controlled, mechanism-focused experimental designs.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-08-14
Inskeep and colleagues connect SMPD4-dependent ceramide production with primary cilia integrity, neural progenitor survival, and cerebellar development using mouse and human iPSC models. The rescue of SMPD4-deficient human cells by exogenous ceramide provides mechanistic support for a lipid–cilium pathway in severe neurodevelopmental disease.